MedTrace Logo

Extended Work Schedules, Sleep Loss and Health

NCT00989534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2016-10-03

No results posted yet for this study

Summary

This study aims to determine whether abnormal bodily rhythms contribute to elevate the risk of diabetes, independently of the amount of sleep loss.

Conditions

  • Sleep

Interventions

BEHAVIORAL

Fixed restricted bedtimes

Sleep restricted to 5 hours per night for 8 nights

BEHAVIORAL

Sleep restriction with circadian misalignment

Sleep restricted to 5 h per day for 8 days, alternating night sleep and day sleep

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2007-12-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00989534 on ClinicalTrials.gov